title: Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
abstract: The switch to an angiogenic phenotype is a fundamental determinant of neoplastic growth and tumor progression. We demonstrate that homozygous deletion of the p53 tumor suppressor gene via homologous recombination in a human cancer cell line promotes the neovascularization and growth of tumor xenografts in nude mice. We find that p53 promotes Mdm2-mediated ubiquitination and proteasomal degradation of the HIF-1alpha subunit of hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that regulates cellular energy metabolism and angiogenesis in response to oxygen deprivation. Loss of p53 in tumor cells enhances HIF-1alpha levels and augments HIF-1-dependent transcriptional activation of the vascular endothelial growth factor (VEGF) gene in response to hypoxia. Forced expression of HIF-1alpha in p53-expressing tumor cells increases hypoxia-induced VEGF expression and augments neovascularization and growth of tumor xenografts. These results indicate that amplification of normal HIF-1-dependent responses to hypoxia via loss of p53 function contributes to the angiogenic switch during tumorigenesis.
authors.affiliation: Johns Hopkins Oncology Center, Departments of Pediatrics and Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 USA.
authors.forename: R
authors.initials: R
authors.lastname: Ravi
authors.forename: B
authors.initials: B
authors.lastname: Mookerjee
authors.forename: Z M
authors.initials: ZM
authors.lastname: Bhujwalla
authors.forename: C H
authors.initials: CH
authors.lastname: Sutter
authors.forename: D
authors.initials: D
authors.lastname: Artemov
authors.forename: Q
authors.initials: Q
authors.lastname: Zeng
authors.forename: L E
authors.initials: LE
authors.lastname: Dillehay
authors.forename: A
authors.initials: A
authors.lastname: Madan
authors.forename: G L
authors.initials: GL
authors.lastname: Semenza
authors.forename: A
authors.initials: A
authors.lastname: Bedi
mesh_terms: D000230:Adenocarcinoma / Q000098:blood supply* / Q000473:pathology; D000818:Animals; D002455:Cell Division / Q000502:physiology; D003110:Colonic Neoplasms / Q000098:blood supply* / Q000473:pathology; D004268:DNA-Binding Proteins / Q000378:metabolism*; D016228:Endothelial Growth Factors / Q000235:genetics; D005838:Genotype; D006801:Humans; D006868:Hydrolysis; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D008222:Lymphokines / Q000235:genetics; D051379:Mice; D009389:Neovascularization, Pathologic; D009687:Nuclear Proteins / Q000378:metabolism*; D010100:Oxygen / Q000378:metabolism; D014157:Transcription Factors; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000502:physiology*; D014452:Ubiquitins / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D004268:DNA-Binding Proteins; D016228:Endothelial Growth Factors; C497442:HIF1A protein, human; C497443:Hif1a protein, mouse; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D008222:Lymphokines; D009687:Nuclear Proteins; D014157:Transcription Factors; D016159:Tumor Suppressor Protein p53; D014452:Ubiquitins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D010100:Oxygen